Follicular dendritic cell sarcoma in the right chest wall

Abstract

Rationale: Follicular dendritic cell sarcoma (FDCS) is a rare malignant tumor that originates from germinal center follicular dendritic cells, and can occur at both nodal and extranodal sites. There are very few described cases of FDCS arising in the chest wall. Patient concerns: A 44-year-old male patient presented with a history of right chest wall pain for 5 months. Diagnoses: Positron emission tomography/computed tomography showed a significant increase in 18 F-fluorodeoxyglucose uptake and multiple small axillary lymph nodes without hypermetabolic lesions. Immunohistochemistry results of a core-needle biopsy indicated FDCS, which was consistent with the postoperative pathological examination. Interventions: The patient underwent tumor resection with lymphadenectomy of level I axillary nodes. No metastasis in the lymph nodes was observed in the postoperative pathological examination. The patient did not accept chemotherapy or radiotherapy. Outcomes: After 18 months, the patient remains in good condition with no evidence of disease recurrence. Lessons: This report highlights a rare case of a FDCS arising in the chest wall. Accurate clinical diagnosis and staging of this rare malignant sarcoma is essential for the developmnt of effective treatment strategies. Preoperative 18 F-fluorodeoxyglucose positron emission tomography/computed tomography scanning combined with core-needle biopsy could provide differentiation between benign and malignant tumors, as well as lymph node involvement and metastatic status.

Death within 9 months in patient with follicular dendritic cell sarcoma of spleen: A case report

“…Current treatment options include surgery, radiotherapy and chemotherapy alone or in combination. Although surgical resection is the preferred treatment, for cases that cannot be resected or patients with tumor recurrence and metastasis after resection, chemotherapy or radiotherapy is still required ( 21 ). In addition, FDCS is regarded as lymphoma or sarcoma according to its tumor cell origin, and thus, cyclophosphamide, epirubicin, oncovin, prednisone (CHOP) chemotherapy is used in certain patients; however, the therapeutic effect of CHOP chemotherapy in patients with FDCS is lower than that in patients with non-Hodgkin's lymphoma.…”

CT features, Pathological findings and Clinical data of Follicular Dendritic Cell Sarcoma in the Mediastinum: Case Report and Literature Review

“…Complete surgical excision is the main treatment option for FDC sarcoma, [22] and adjuvant therapy (chemotherapy or radiation), which greatly improves survival rates. [23] Poor prognosis signs of a high mitotic activity include intra-lesion necrosis, a mass more than 6 cm, intraabdominal lesions, and a high proliferative lesion. [3] Conclusion FDC sarcoma is not very common.…”

Untitled

“…Complete surgical excision is the main treatment option for FDC sarcoma, [22] and adjuvant therapy (chemotherapy or radiation), which greatly improves survival rates. [23] Poor prognosis signs of a high mitotic activity include intra-lesion necrosis, a mass more than 6 cm, intraabdominal lesions, and a high proliferative lesion. [3] Conclusion FDC sarcoma is not very common.…”